---
templateKey: 'index-page'
title: Combining pioneering science with the power of nature 
image: /img/Hero_image@2x.png
mainpitch:
  title: Who is Apollon
  description: >
    Apollon’s strategy is to become the proven global medical cannabis company licensed to develop full spectrum formulations based on real life clinical patient data. 


    It aims to create a globally recognised brand synonymous with quality, consistency potency on a range of products for a variety of conditions within the medical cannabis space.
  subtitle: Our Strategy
  subdescription: >  
    **Our strategy is to become the premiere global medical cannabis company legally licensed to develop successful personalised clinical treatments utilizing artificial intelligence on clinical trial patient data.**


    Apollon’s Research & Development Licence allows drug discovery using THC and other cannabinoids. This allows Apollon to be the rare European listed company conducting medically supervised trials using THC to develop new therapeutics.  
heading: APOLLON FORMULARIES.
featuretitle: Investment Highlights
intro:
  blurbs:
    - image: /img/cost.png
      header: Low Cost
      text: |
        High quality production.
    - image: /img/cycles.png
      header: 3.5 Outdoor growing cycles
      text: |
        per year, ideal climate and soil conditions
    - image: /img/granted.png
      header: Conditional approvals/ Granted Licences
      text: >
        cultivation, processing, extraction, transportation, retail
        (therapeutic) and R&D
    - image: /img/patent.png
      header: 7 Patents pending
      text: |
        for medical cannibis products for sale with multiyear clinical trials
    - image: /img/trials.png
      header: Backed by clinical trials
      text: |
        true efficacy of Apollon's cannabis-based medicines is measured   
    - image: /img/global.png
      header: Stong global recognition
      text: |
        of Jamaican growers and brands             
main:
  heading: Our Products
  description: >
    **Apollon** has created and obtained proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.


    Many of these formulations were created using Apollon’s proprietary artificial intelligence techniques and include:

    * Apollon NAUSEA™

    * Apollon PAIN™

    * Apollon SLEEP™

    * Apollon ANTI-INFLAMMATORY™

    * Apollon SEIZURES™

    * Apollon APPETITE™
    
    * Apollon CANCER™ (APM™) – High Times Cannabis Cup 1 st Place Winner
carousel: 
  slides: 
    - image: /img/our_strategy_01@2x.jpg 
      alt: Provide physician supervised clinical trials for patient outcomes validation
    - image: /img/our_strategy_02@2x.jpg
      alt: Accurately determine appropriate disease and patient specific formulations
    - image: /img/our_strategy_03@2x.jpg
      alt: Provide quality dose controlled medical cannabis pharmaceutical production
    - image: /img/our_strategy_04@2x.jpg
      alt: Provide quality controlled legal growth of medical cannabis strains
    - image: /img/our_strategy_05@2x.jpg
      alt: Be capable of providing consistent dosing globally and legally
    - image: /img/our_strategy_06@2x.jpg
      alt: Patented formulas to be made available for third party licensing
    - image: /img/our_strategy_07@2x.jpg 
      alt: Patented formulations, along with clinically proven data, allows for potential partnerships with ‘Big Pharma’      
               
products:
  slides:
    - image: /img/01_thc-vape@2x.jpg
      alt: Apollon NAUSEA
    - image: /img/02_cbd-thc-oral-spray@2x.jpg
      alt: Apollon APPETITE
    - image: /img/03_cbd-capsules@2x.jpg
      alt: Apollon CANCER
    - image: /img/04_thc-live-resin-gelato@2x.jpg
      alt: Apollon PAIN
    - image: /img/05_cbd-caviar@2x.jpg
      alt: Apollon NAUSEA


---
